Who invested in Prevail?
Prevail's investors include OrbiMed, Alexandria Real Estate Equities, Omega Funds, EcoR1 Capital and Boxer Capital, and 4 more on record.
Who invested in Prevail
One round we have observed, with the 9 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$75Mraised across 1 round since 2018, from 1 source
- Latest round
- Series A, $75MMar 2018
- Investors
- 9
The rounds
- Mar 2018Series A$75M
OrbiMed
Alexandria Real Estate Equities
Omega Funds
EcoR1 Capital
Boxer Capital- BVF Partners
- Adage
- Pontifax
- RA
Reported by FinSMEsSEC filing: $500K sold, first sale Dec 2017
Everyone who backed them
BVF PartnersVC firm1round
Adageno record of our own yet1round
Pontifaxno record of our own yet1round
RAno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Prevail as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Prevail
How much has Prevail raised?
Prevail has raised $75M across 1 round since 2018.
When did Prevail last raise?
Prevail's most recent round was a Series A of $75M in Mar 2018.
What was Prevail's biggest round?
Its most recent round, $75M in Mar 2018, is also its largest on record.
Who backed Prevail first?
Prevail's first round on record, in Mar 2018, was backed by OrbiMed, Alexandria Real Estate Equities and Omega Funds and 6 others.
What stage is Prevail at?
Prevail's latest named round is a Series A, in Mar 2018.
Companies like Prevail
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.